Stephens Lowers Amedisys (NASDAQ:AMED) Price Target to $106.00
Amedisys (NASDAQ:AMED - Get Rating) had its price objective lowered by investment analysts at Stephens from ...
Read moreAmedisys (NASDAQ:AMED - Get Rating) had its price objective lowered by investment analysts at Stephens from ...
Read moreStephens Inc. AR decreased its holdings in Vanguard S&P 500 Value ETF (NYSEARCA:VOOV – Get Rating) ...
Read moreC.H. Robinson Worldwide (NASDAQ:CHRW - Get Rating) had its price target increased by analysts at Stephens ...
Read more© 2022 TheDailyStock.News